Literature DB >> 32996109

Feasibility of computed tomography-based assessment of skeletal muscle mass in hemodialysis patients.

Tomoaki Takata1, Aki Motoe2, Katsumi Tanida3, Sosuke Taniguchi2, Ayami Ida2, Kentaro Yamada4, Shintaro Hamada4, Masaya Ogawa2, Marie Yamamoto4, Yukari Mae4, Takuji Iyama4, Munehiro Taniguchi3, Akihisa Nakaoka2, Hajime Isomoto4.   

Abstract

BACKGROUND: Sarcopenia is a major health issue especially in patients on maintenance hemodialysis. Low skeletal muscle mass is included in the diagnostic criteria for sarcopenia. The skeletal muscle mass is usually evaluated by modalities such as bioimpedance analysis (BIA) or dual-energy X-ray absorptiometry, however the assessment of skeletal muscle mass using computed tomography (CT) images has not been established. The purpose of the study was to investigate the feasibility of the assessment of skeletal muscle mass using CT images in hemodialysis patients.
METHODS: Skeletal muscle mass index (SMI) was measured by BIA and psoas muscle index (PMI) was measured by cross-sectional CT images in 131 patients. The relationship between SMI and PMI and the diagnostic ability of PMI for low muscle mass were evaluated. Furthermore, the patients were followed up and long-term survival in patients with low and high PMI were compared.
RESULTS: PMI measured at the L3 vertebral level was strongly correlated with SMI (r = 0.597, p < 0.001). Age, sex, and SMI were the influencing factors for PMI. Patients with low PMI showed higher incidence rates of mortality during the follow up.
CONCLUSIONS: PMI assessed by CT image can be an alternative to BIA in patients on hemodialysis.

Entities:  

Keywords:  Bioimpedance analysis; Muscle wasting; Psoas muscle; Sarcopenia

Year:  2020        PMID: 32996109     DOI: 10.1007/s40620-020-00871-5

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  18 in total

1.  Using two different algorithms to determine the prevalence of sarcopenia.

Authors:  Daisuke Yoshida; Takao Suzuki; Hiroyuki Shimada; Hyuntae Park; Hyuma Makizako; Takehiko Doi; Yuya Anan; Kota Tsutsumimoto; Kazuki Uemura; Tadashi Ito; Sangyoon Lee
Journal:  Geriatr Gerontol Int       Date:  2014-02       Impact factor: 2.730

2.  Prognostic value of muscle atrophy in cirrhosis using psoas muscle thickness on computed tomography.

Authors:  François Durand; Sophie Buyse; Claire Francoz; Cédric Laouénan; Onorina Bruno; Jacques Belghiti; Richard Moreau; Valérie Vilgrain; Dominique Valla
Journal:  J Hepatol       Date:  2014-03-06       Impact factor: 25.083

3.  Is osteoporosis a predictor for future sarcopenia or vice versa? Four-year observations between the second and third ROAD study surveys.

Authors:  N Yoshimura; S Muraki; H Oka; T Iidaka; R Kodama; H Kawaguchi; K Nakamura; S Tanaka; T Akune
Journal:  Osteoporos Int       Date:  2016-11-24       Impact factor: 4.507

4.  Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk.

Authors:  Hongqi Ren; Dehua Gong; Fengyu Jia; Bin Xu; Zhihong Liu
Journal:  Ren Fail       Date:  2016-01-07       Impact factor: 2.606

5.  Proposal for new diagnostic criteria for low skeletal muscle mass based on computed tomography imaging in Asian adults.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Ahmed Hammad; Yumiko Tamai; Nobuya Inagaki; Shinji Uemoto
Journal:  Nutrition       Date:  2016-05-04       Impact factor: 4.008

6.  Risk of Fracture in Women with Sarcopenia, Low Bone Mass, or Both.

Authors:  Rebekah Harris; Yuefang Chang; Kristen Beavers; Deepika Laddu-Patel; Jennifer Bea; Karen Johnson; Meryl LeBoff; Catherine Womack; Robert Wallace; Wenjun Li; Carolyn Crandall; Jane Cauley
Journal:  J Am Geriatr Soc       Date:  2017-09-27       Impact factor: 5.562

7.  Comparative associations of muscle mass and muscle strength with mortality in dialysis patients.

Authors:  Naohito Isoyama; Abdul Rashid Qureshi; Carla Maria Avesani; Bengt Lindholm; Peter Bàràny; Olof Heimbürger; Tommy Cederholm; Peter Stenvinkel; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2014-07-29       Impact factor: 8.237

8.  Sarcopenia and impairment in cognitive and physical performance.

Authors:  Magdalena I Tolea; James E Galvin
Journal:  Clin Interv Aging       Date:  2015-03-30       Impact factor: 4.458

9.  Sarcopenia: revised European consensus on definition and diagnosis.

Authors:  Alfonso J Cruz-Jentoft; Gülistan Bahat; Jürgen Bauer; Yves Boirie; Olivier Bruyère; Tommy Cederholm; Cyrus Cooper; Francesco Landi; Yves Rolland; Avan Aihie Sayer; Stéphane M Schneider; Cornel C Sieber; Eva Topinkova; Maurits Vandewoude; Marjolein Visser; Mauro Zamboni
Journal:  Age Ageing       Date:  2019-01-01       Impact factor: 10.668

10.  Sarcopenic obesity and risk of cardiovascular disease and mortality: a population-based cohort study of older men.

Authors:  Janice L Atkins; Peter H Whincup; Richard W Morris; Lucy T Lennon; Olia Papacosta; S Goya Wannamethee
Journal:  J Am Geriatr Soc       Date:  2014-01-15       Impact factor: 5.562

View more
  6 in total

1.  Low skeletal muscle mass by computerized tomography is associated with increased mortality risk in end-stage kidney disease patients on hemodialysis.

Authors:  Alice Sabatino; Giuseppe Regolisti; Giuseppe Benigno; Francesca Di Mario; Carla Maria Avesani; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2021-10-07       Impact factor: 3.902

Review 2.  Diagnosis, prevalence, and mortality of sarcopenia in dialysis patients: a systematic review and meta-analysis.

Authors:  Xiaoyu Shu; Taiping Lin; Hui Wang; Yanli Zhao; Tingting Jiang; Xuchao Peng; Jirong Yue
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-01-05       Impact factor: 12.910

3.  Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients.

Authors:  Tomoaki Takata; Yukari Mae; Kentaro Yamada; Sosuke Taniguchi; Shintaro Hamada; Marie Yamamoto; Takuji Iyama; Hajime Isomoto
Journal:  BMC Nephrol       Date:  2021-04-16       Impact factor: 2.388

4.  Association between the psoas muscle index and hospitalization for pneumonia in patients undergoing hemodialysis.

Authors:  Kosei Yamaguchi; Mineaki Kitamura; Takahiro Takazono; Shuntaro Sato; Kazuko Yamamoto; Satoko Notomi; Kenji Sawase; Takashi Harada; Satoshi Funakoshi; Hiroshi Mukae; Tomoya Nishino
Journal:  BMC Nephrol       Date:  2021-11-27       Impact factor: 2.388

5.  Psoas muscle index and psoas muscle density as predictors of mortality in patients undergoing hemodialysis.

Authors:  Takahiro Yajima; Maiko Arao; Kumiko Yajima
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

6.  Usefulness of computed tomography-measured psoas muscle thickness per height for predicting mortality in patients undergoing hemodialysis.

Authors:  Takahiro Yajima; Maiko Arao; Kumiko Yajima; Hiroshi Takahashi
Journal:  Sci Rep       Date:  2021-09-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.